- Indivior was charged by US authorities over a series of criminal offences including mail, wire and health fraud. The company denied the allegations, citing they were without merit, but also warned an adverse verdict may hurt profits.

'The company believes the allegations are unsupported by the facts and the law. Key allegations have been contradicted by the U.S. government's scientific agencies, the Food and Drug Administration and the Centers for Disease Control,' Indivior said.

The indictment included twenty-eight felony counts - one count of conspiracy to commit mail, wire and health care fraud; one count of health care fraud; four counts of mail fraud; and twenty-two counts of wire fraud.

The allegations were based on actions that occurred almost exclusively prior to Indivior becoming an independent company in its demerger from Reckitt Benckiser Group plc at the end of 2014.

Indivior warned that an 'adverse verdict may have a material adverse effect on the company and its financial position and outlook.'

'While the company cannot predict the timing with certainty, similar cases can take twelve months or more to be heard,' it added. At 8:03am: [LON:INDV] Indivior Plc share price was -25.95p at 80p

Story provided by